Total Funding
48
85
Total FundingPost-IPO Debt raised
Growth Score
-3 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2770
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Esteban Santos: Executive Vice President, OperationsPast Role: Amgen, Senior Vice President, Manufacturing- Howard Chang: SVP of Research
About the Company
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of
oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
